Literature DB >> 25624363

Perioperative Implications of End-stage Renal Disease in Orthopaedic Surgery.

Julian O Carlo, Phinit Phisitkul, Kantima Phisitkul, Sundara Reddy, Annunziato Amendola.   

Abstract

End-stage renal disease is a prevalent condition that substantially impacts a patient's quality of life. As medical advancements improve function and rates of survival, the number of persons with end-stage renal disease will grow, with orthopaedic surgeons increasingly encountering patients with the disease in their practice. End-stage renal disease is a complex medical condition that is often associated with multiple medical comorbidities. Orthopaedic surgery in patients with this disease is associated with at least a twofold risk of complications and mortality compared with a population without end-stage renal disease. Patients are at an increased risk for cardiovascular, metabolic, hematologic, and infectious complications. Orthopaedic surgeons should be familiar with pertinent issues in the preoperative evaluation and the postoperative management of these patients and should understand the risks of surgery to better inform patients and family. Careful coordination with consulting specialists is necessary to minimize morbidity and improve outcome. Copyright 2015 by the American Academy of Orthopaedic Surgeons.

Entities:  

Mesh:

Year:  2015        PMID: 25624363     DOI: 10.5435/JAAOS-D-13-00221

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  2 in total

1.  Hip fusion takedown with total knee and hip arthroplasty in a patient with end-stage chronic kidney disease - a case report and narrative literature review.

Authors:  Wojciech Konarski; Tomasz Poboży; Martyna Hordowicz
Journal:  Orthop Rev (Pavia)       Date:  2022-05-31

2.  A multi-center study on the association between serum magnesium levels and allostatic load in hemodialysis patients.

Authors:  Yingxin Zhang; Zhengling Yang; Huan Yang; Xiuyong Li; Zhi Liu; Youwei Bai; Guangrong Qian; Han Wu; Ji Li; Yuwen Guo; Shanfei Yang; Lei Chen; Jian Yang; Jiuhuai Han; Shengyin Ma; Jing Yang; Linfei Yu; Runzhi Shui; Xiping Jin; Hongyu Wang; Fan Zhang; Tianhao Chen; Xinke Li; Xiaoying Zong; Li Liu; Jihui Fan; Wei Wang; Yong Zhang; Guangcai Shi; Deguang Wang; Shuman Tao
Journal:  Front Physiol       Date:  2022-10-03       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.